624 related articles for article (PubMed ID: 17371277)
1. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
2. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
3. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
[TBL] [Abstract][Full Text] [Related]
4. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
5. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line.
Hudson EA; Howells LM; Gallacher-Horley B; Fox LH; Gescher A; Manson MM
BMC Cancer; 2003 Jan; 3():2. PubMed ID: 12525265
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
8. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
9. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
[TBL] [Abstract][Full Text] [Related]
10. Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.
Carbone PP; Pirsch JD; Thomas JP; Douglas JA; Verma AK; Larson PO; Snow S; Tutsch KD; Pauk D
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):657-61. PubMed ID: 11401916
[TBL] [Abstract][Full Text] [Related]
11. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target.
Müller IB; Das Gupta R; Lüersen K; Wrenger C; Walter RD
Mol Biochem Parasitol; 2008 Jul; 160(1):1-7. PubMed ID: 18455248
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
[TBL] [Abstract][Full Text] [Related]
14. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
16. Effects of suramin on polyamine metabolism in B16 murine melanoma cells.
Gritli-Linde A; Björkman U; Delle U; Frostesjö L; Hultborn R; Hultén K; Johansson BR; Nannmark U; Linde A
Anticancer Res; 1998; 18(2A):855-62. PubMed ID: 9615732
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the antiproliferative activity of human interferon by polyamine depletion.
Kovach JS; Svingen PA
Cancer Treat Rep; 1985 Jan; 69(1):97-103. PubMed ID: 3917854
[TBL] [Abstract][Full Text] [Related]
18. [The effect of chemically modified polyamine analogs on polyamine and putrescine biosynthesis in a cell-free test system from a rat hepatoma].
Fedoronchuk TV; Siatkin SP; Lulle IZh; Ianson IaIa; Lidak MIu; Berezov TT
Biull Eksp Biol Med; 1993 Sep; 116(9):256-8. PubMed ID: 8117993
[TBL] [Abstract][Full Text] [Related]
19. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
Kucharzewska P; Welch JE; Svensson KJ; Belting M
Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
